Have a personal or library account? Click to login
Increased expression of Cardiotrophin-1 in cardiomyopathy patients Cover

Increased expression of Cardiotrophin-1 in cardiomyopathy patients

By: S Sharif,  A Saleem,  S Naz,  F Rashid,  M Iqtedar,  A Kaleem and  A Latif  
Open Access
|Jul 2021

Figures & Tables

Figure 1

Cardiotrophin-1 gene expression in the control and CM groups.
Cardiotrophin-1 gene expression in the control and CM groups.

Figure 2

Scattered plot showing correlation between CT-1 gene and BMI in CM group.
Scattered plot showing correlation between CT-1 gene and BMI in CM group.

Demographic parameters of the cardiomyopathy and control groups_

ParametersCM Group (n=20)Control Group (n=20)
Age (years)40.10±6.0335.00±3.71
BMI (kg/m2)25.11±0.3924.22±0.66
SBP (mmHg)124.0±0.7103.0±0.9
DBP (mmHg)83.0±0.879.0±1.5
CT-1 (arbitrary units)5.29±0.341.00

Prevalence of physical activity, etiological attributes and symptomatology in the cardiomyopathy group_

VariablesCM Group (n=40)
Physical activity (%)
vigorous5.0
moderate20.0
sedentary75.0
Etiological attributes (%)
idiopathic65.0
nutritional15.0
multifactorial15.0
Symptomatology (%)
breathless85.0
palpitations75.0
chest pain45.0

Correlation between the cardiotrophin-1 gene and demographic parameters in cardiomyopathy group_

Parametersr Valuesp Values
Age (years)0.54a<0.05
BMI (kg/m2)0.46b<0.01
SBP (mmHg)–0.079>0.05
DBP (mmHg)0.069>0.05
Language: English
Page range: 21 - 26
Published on: Jul 27, 2021
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2021 S Sharif, A Saleem, S Naz, F Rashid, M Iqtedar, A Kaleem, A Latif, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.